China Universal Asset Management Company’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
NFT
HWAM
JAM
1CM
SGA
China Universal Asset Management Company's KURA Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Kura Oncology (KURA) stake by 8.5% in Q2 2026, selling an estimated $12.4K and leaving 14,128 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #375.
China Universal Asset Management Company first reported a position in KURA in Q3 2022 and has held it in 16 quarters since. The position peaked at $333K in Q1 2024. 117 funds tracked by Wall St. Rank hold KURA as of Q2 2026.
- China Universal Asset Management Company held 14,128 shares of Kura Oncology worth $155K as of Q2 2026.
- China Universal Asset Management Company sold 1,314 Kura Oncology shares in Q2 2026, an estimated $12.4K.
- Kura Oncology made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #375 holding.
- China Universal Asset Management Company first reported a position in Kura Oncology in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Kura Oncology position peaked at $333K in Q1 2024.
- 117 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.